Michel van Gelder

High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

Monique Terwijn, Wim L.J. van Putten, Angèle Kelder et al. · Journal of Clinical Oncology · 2013 · 449 citations · Full text

Medicine, Hematology, Oncology +16

Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells

Subhashis Sarkar, Wilfred T.V. Germeraad, Kasper M.A. Rouschop et al. · PLoS ONE · 2013 · 211 citations · Full text

Life Sciences, Immunology, Oncology +17

Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial

Annoek E. C. Broers, Cornelis N. de Jong, Katerina Bakunina et al. · Blood Advances · 2022 · 127 citations · Full text

Medicine, Hematology, Immunology +17

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò et al. · Leukemia · 2021 · 94 citations · Full text

Medicine, Internal Medicine, Oncology +14

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

Gerald Wulf, Bettina Altmann, Marita Ziepert et al. · Leukemia · 2020 · 91 citations · Full text

Medicine, Immunology, Oncology +11